Clinical Trial Update: Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas [Phase 4]

View source ↗

Summary

Phase 4 trial comparing methotrexate to interferon-alfa 2b in patients with primary cutaneous T-cell lymphomas (mycosis fungoides) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma T-cell Cutaneous
• Mycosis Fungoides

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Polish Lymphoma Research Group | Conditions: Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides | Phase 4 | Status: TERMINATED